Nordea Investment Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,000
Closed -$300K 981
2022
Q1
$300K Hold
4,000
﹤0.01% 938
2021
Q4
$600K Hold
4,000
﹤0.01% 890
2021
Q3
$810K Hold
4,000
﹤0.01% 847
2021
Q2
$849K Sell
4,000
-55,023
-93% -$10.1M ﹤0.01% 834
2021
Q1
$10.6M Sell
59,023
-230
-0.4% -$45.8K 0.02% 369
2020
Q4
$6.61M Buy
+59,253
New +$6.3M 0.01% 446

Other funds holding NVAX

Nordea Investment Management's NVAX Position: Q2 2022 in Review

Nordea Investment Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 4,000 shares — an estimated $300K sold.

Nordea Investment Management first reported a position in NVAX in Q4 2020 and held it in 6 quarters. The position peaked at $10.6M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Nordea Investment Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Nordea Investment Management sold 4,000 Novavax shares in Q2 2022, an estimated $300K.
  • Nordea Investment Management first reported a position in Novavax in Q4 2020 and held it in 6 quarters.
  • Nordea Investment Management's Novavax position peaked at $10.6M in Q1 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Nordea Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.